 vivo administration granulocyte colony-stimulating factor G-CSF granulocyte-macrophage CSF combination allogeneic murine hematopoietic stem cell transplantation BALB/c mice Gy total body irradiation TBI bone marrow BM spleen cells donor mice recombinant cytokines IP effect neutrophil recovery rate graft-v-host disease GVHD survival reagents granulocyte-colony-stimulating factor G-CSF granulocyte-macrophage CSF GM-CSF combination effective combination absolute neutrophil account ANC control value day posttransplant combination G-CSF mean ANC /L control value G-CSF mean ANC combination GM-CSF mean ANC combination G-CSF GM-CSF mean ANC day posttransplant effective combination ANC combination G-CSF GM-CSF mean ANC control value G-CSF mean ANC doses G-CSF GM-CSF deleterious effect incidence severity GVHD GM-CSF improved survival contrast doses equal ng early mortality suggestion doses ng increased late mortality exacerbation GVHD model value use hematopoietic growth factors marrow allograft recipients